IL118525A - Medicinal preparations of piperidinoalkanol in liquid form, for oral administration - Google Patents

Medicinal preparations of piperidinoalkanol in liquid form, for oral administration

Info

Publication number
IL118525A
IL118525A IL11852596A IL11852596A IL118525A IL 118525 A IL118525 A IL 118525A IL 11852596 A IL11852596 A IL 11852596A IL 11852596 A IL11852596 A IL 11852596A IL 118525 A IL118525 A IL 118525A
Authority
IL
Israel
Prior art keywords
solvent system
pharmaceutical composition
oral pharmaceutical
piper
solution form
Prior art date
Application number
IL11852596A
Other languages
English (en)
Hebrew (he)
Other versions
IL118525A0 (en
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of IL118525A0 publication Critical patent/IL118525A0/xx
Publication of IL118525A publication Critical patent/IL118525A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
IL11852596A 1995-06-06 1996-06-02 Medicinal preparations of piperidinoalkanol in liquid form, for oral administration IL118525A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/469,392 US5574045A (en) 1995-06-06 1995-06-06 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Publications (2)

Publication Number Publication Date
IL118525A0 IL118525A0 (en) 1996-10-16
IL118525A true IL118525A (en) 2001-07-24

Family

ID=23863607

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11852596A IL118525A (en) 1995-06-06 1996-06-02 Medicinal preparations of piperidinoalkanol in liquid form, for oral administration

Country Status (22)

Country Link
US (1) US5574045A (hu)
EP (1) EP0831820B1 (hu)
JP (1) JP4091655B2 (hu)
KR (1) KR100509316B1 (hu)
CN (1) CN1139386C (hu)
AR (1) AR002191A1 (hu)
AT (1) ATE256465T1 (hu)
AU (1) AU707218B2 (hu)
CA (1) CA2218643C (hu)
DE (1) DE69631132T2 (hu)
DK (1) DK0831820T3 (hu)
ES (1) ES2211954T3 (hu)
HU (1) HU227710B1 (hu)
IL (1) IL118525A (hu)
MX (1) MX9709453A (hu)
NO (1) NO318029B1 (hu)
NZ (1) NZ307370A (hu)
PT (1) PT831820E (hu)
SI (1) SI0831820T1 (hu)
TW (1) TW460283B (hu)
WO (1) WO1996039139A1 (hu)
ZA (1) ZA964517B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CA2449419C (en) * 1994-05-18 2011-09-06 Aventis Pharmaceuticals Inc. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
EP0812195B1 (en) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol compounds
ES2107375B1 (es) * 1995-08-01 1998-07-01 Almirall Prodesfarma Sa Formulaciones farmaceuticas liquidas de ebastina por via oral.
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
IL133420A (en) * 1997-08-26 2004-07-25 Aventis Pharma Inc Tablet-shaped pharmaceutical preparation containing a combination of piperidinoalkanol and antihistamines and reduces symptomatic congestion
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6613906B1 (en) 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
US20060205752A1 (en) * 2005-03-14 2006-09-14 Keith Whitehead Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3966949A (en) * 1973-10-12 1976-06-29 Richardson-Merrell Inc. Pharmaceutical compositions and preparing same
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
EP0111114A3 (de) * 1982-11-06 1985-10-09 Telefonbau und Normalzeit GmbH Schaltungsanordnung für eine Fernsprechvermittlungsanlage, insbesondere Fernsprechnebenstellenanlage mit zusätzlichem Datenverkehr
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US4966061A (en) * 1989-03-27 1990-10-30 Riera John F Tube cutting apparatus

Also Published As

Publication number Publication date
MX9709453A (es) 1998-02-28
CN1139386C (zh) 2004-02-25
HU227710B1 (en) 2011-12-28
DK0831820T3 (da) 2004-04-13
SI0831820T1 (en) 2004-04-30
HUP9802096A2 (hu) 1999-01-28
KR100509316B1 (ko) 2005-11-25
NO975680D0 (no) 1997-12-05
HUP9802096A3 (en) 1999-06-28
NO975680L (no) 1998-02-05
DE69631132D1 (de) 2004-01-29
ES2211954T3 (es) 2004-07-16
JPH11506115A (ja) 1999-06-02
AU5669596A (en) 1996-12-24
ATE256465T1 (de) 2004-01-15
EP0831820B1 (en) 2003-12-17
US5574045A (en) 1996-11-12
IL118525A0 (en) 1996-10-16
JP4091655B2 (ja) 2008-05-28
PT831820E (pt) 2004-05-31
ZA964517B (en) 1996-12-09
TW460283B (en) 2001-10-21
NO318029B1 (no) 2005-01-24
CA2218643A1 (en) 1996-12-12
AU707218B2 (en) 1999-07-08
WO1996039139A1 (en) 1996-12-12
DE69631132T2 (de) 2004-08-19
CN1187125A (zh) 1998-07-08
AR002191A1 (es) 1998-01-07
EP0831820A1 (en) 1998-04-01
KR19990022504A (ko) 1999-03-25
CA2218643C (en) 2001-12-11
NZ307370A (en) 1999-07-29

Similar Documents

Publication Publication Date Title
US20050220877A1 (en) Bilayer tablet comprising an antihistamine and a decongestant
US4829064A (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
US20060258640A1 (en) Use of Flibanserin in the treatment of chronic pain
US4975426A (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
RU99125326A (ru) Фармацевтическая композиция для объединения пиперидиноалканола с противоотечным агентом
KR20010013543A (ko) 피페리디노알칸올-충혈완화제 조합용 제약 조성물
EP0287341B1 (en) Rectally absorbable form of l-dopa
AU707218B2 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
AU8744398A (en) Compositions and methods for treating respiratory disorders
MXPA97009453A (en) Oral pharmaceutical composition of piperidinoalcanol compounds in the form of soluc
US5049568A (en) Liquid pharmaceutical composition for piperidinoalkanol derivatives
WO2019241020A1 (en) Serdexmethylphenidate conjugates, compositions and methods of use thereof
US20080206331A1 (en) Tablet comprising efletirizine and pseudoephedrine
JP2005187328A (ja) イブプロフェン含有解熱鎮痛組成物、及び感冒薬
US4672061A (en) Antiinflammatory compositions and methods
AU1549499A (en) Onset-hastended/enhanced analgesia

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired